PT1124546E - Um metodo para prevenir reduzir e tratar a cistite usando acido hialuronico - Google Patents
Um metodo para prevenir reduzir e tratar a cistite usando acido hialuronicoInfo
- Publication number
- PT1124546E PT1124546E PT99952186T PT99952186T PT1124546E PT 1124546 E PT1124546 E PT 1124546E PT 99952186 T PT99952186 T PT 99952186T PT 99952186 T PT99952186 T PT 99952186T PT 1124546 E PT1124546 E PT 1124546E
- Authority
- PT
- Portugal
- Prior art keywords
- hyaluronic acid
- preventing
- reducing
- treating cystitis
- preventing reducing
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 3
- 229920002674 hyaluronan Polymers 0.000 title abstract 3
- 229960003160 hyaluronic acid Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 201000003146 cystitis Diseases 0.000 title 1
- 210000003932 urinary bladder Anatomy 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000002710 external beam radiation therapy Methods 0.000 abstract 1
- 201000007608 radiation cystitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10518498P | 1998-10-22 | 1998-10-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1124546E true PT1124546E (pt) | 2004-08-31 |
Family
ID=22304511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99952186T PT1124546E (pt) | 1998-10-22 | 1999-10-22 | Um metodo para prevenir reduzir e tratar a cistite usando acido hialuronico |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6667296B1 (enExample) |
| EP (1) | EP1124546B1 (enExample) |
| JP (1) | JP4685242B2 (enExample) |
| AT (1) | ATE264674T1 (enExample) |
| AU (1) | AU761158B2 (enExample) |
| CA (1) | CA2347110C (enExample) |
| DE (1) | DE69916643T2 (enExample) |
| DK (1) | DK1124546T3 (enExample) |
| ES (1) | ES2219070T3 (enExample) |
| NZ (1) | NZ511068A (enExample) |
| PT (1) | PT1124546E (enExample) |
| WO (1) | WO2000024387A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9906619D0 (en) † | 1999-03-23 | 1999-05-19 | Zeneca Resins Bv | Compositions |
| US20070173479A1 (en) * | 2003-12-10 | 2007-07-26 | Keryx Biopharmaceuticals, Inc. | Methods Using Sulodexide for the Treatment of Bladder Disease |
| JP2007233949A (ja) * | 2006-03-03 | 2007-09-13 | Kyoto Univ | 排尿管理システム |
| ITMI20061030A1 (it) | 2006-05-26 | 2007-11-27 | Altergon Sa | Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica |
| DE102006060953A1 (de) | 2006-12-12 | 2008-08-07 | Farco-Pharma Gmbh | Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes |
| HUP0900717A3 (en) * | 2009-11-18 | 2012-02-28 | Richter Gedeon Nyrt | Pharmaceutical composition for urological use containing zinc hyaluronate |
| EP3960215B1 (en) | 2009-12-15 | 2024-10-16 | Incept, LLC | Implants and biodegradable fiducial markers |
| RU2557949C1 (ru) * | 2014-08-14 | 2015-07-27 | Общество с ограниченной ответственностью "КОЛЕТЕКС" | Способ лечения лучевого и интерстициального цистита |
| WO2016146573A1 (en) * | 2015-03-13 | 2016-09-22 | Repoceuticals Aps | Melatonin for preventing and treating radiation cystitis |
| RU2676431C1 (ru) * | 2018-02-26 | 2018-12-28 | Федеральное государственное бюджетное учреждение "Российский научный центр радиологии и хирургических технологий имени академика А.М. Гранова" Министерства здравоохранения Российской Федерации (ФГБУ "РНЦРХТ им. ак. А.М. Гранова" Минздрава России) | Способ моделирования лучевого цистита |
| EP3810125B1 (en) * | 2018-06-03 | 2025-07-23 | Glycomira Therapeutics, Inc. | Sulfated polysaccharide for use in preventing oral mucositis after exposure to ionizing radiation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN181358B (enExample) | 1995-02-14 | 1998-05-30 | Bioniche Inc | |
| US5880108A (en) * | 1995-02-14 | 1999-03-09 | Bioniche, Inc. | Method for treating the internal urinary bladder and associated structures using hyaluronic acid |
| CA2154103C (en) * | 1995-07-18 | 1998-02-24 | Samuel Simon Asculai | Treatment of mucous membrane disease, trauma or condition and for the relief of pain |
| US6232301B1 (en) * | 1996-12-27 | 2001-05-15 | Seikagaku Corporation | Remedies for bladder disorders |
-
1999
- 1999-10-22 NZ NZ511068A patent/NZ511068A/en not_active IP Right Cessation
- 1999-10-22 DE DE69916643T patent/DE69916643T2/de not_active Expired - Lifetime
- 1999-10-22 PT PT99952186T patent/PT1124546E/pt unknown
- 1999-10-22 ES ES99952186T patent/ES2219070T3/es not_active Expired - Lifetime
- 1999-10-22 CA CA002347110A patent/CA2347110C/en not_active Expired - Lifetime
- 1999-10-22 AU AU64558/99A patent/AU761158B2/en not_active Ceased
- 1999-10-22 DK DK99952186T patent/DK1124546T3/da active
- 1999-10-22 AT AT99952186T patent/ATE264674T1/de active
- 1999-10-22 WO PCT/CA1999/000994 patent/WO2000024387A2/en not_active Ceased
- 1999-10-22 US US09/830,063 patent/US6667296B1/en not_active Expired - Lifetime
- 1999-10-22 JP JP2000577997A patent/JP4685242B2/ja not_active Expired - Lifetime
- 1999-10-22 EP EP99952186A patent/EP1124546B1/en not_active Expired - Lifetime
-
2003
- 2003-11-10 US US10/705,255 patent/US20040152662A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1124546B1 (en) | 2004-04-21 |
| US20040152662A1 (en) | 2004-08-05 |
| ES2219070T3 (es) | 2004-11-16 |
| WO2000024387A3 (en) | 2000-08-03 |
| DE69916643T2 (de) | 2005-04-28 |
| ATE264674T1 (de) | 2004-05-15 |
| EP1124546A2 (en) | 2001-08-22 |
| CA2347110C (en) | 2008-08-26 |
| JP4685242B2 (ja) | 2011-05-18 |
| US6667296B1 (en) | 2003-12-23 |
| DK1124546T3 (da) | 2004-08-09 |
| AU761158B2 (en) | 2003-05-29 |
| AU6455899A (en) | 2000-05-15 |
| CA2347110A1 (en) | 2000-05-04 |
| JP2002528410A (ja) | 2002-09-03 |
| DE69916643D1 (de) | 2004-05-27 |
| NZ511068A (en) | 2003-10-31 |
| WO2000024387A2 (en) | 2000-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU666413B2 (en) | Antiallergic composition for opthalmic or nasal use | |
| PT1124546E (pt) | Um metodo para prevenir reduzir e tratar a cistite usando acido hialuronico | |
| DE60023138D1 (de) | Verwendung eines biologisch abbaubaren Polymers | |
| DE69434258D1 (de) | Mikroverkapselte 1,2-benzazole | |
| NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
| BR0112361A (pt) | Métodos para tratamento de condições oculares mediadas por inflamação | |
| CA2390295A1 (en) | A method for chemoprevention of prostate cancer | |
| BR9811099A (pt) | Inibidores de urocinase | |
| WO2002076499A3 (en) | Combination treatment of pancreatic cancer | |
| AU3475097A (en) | Substituted cyclopentane compounds useful as neuraminidase inhibitors | |
| PT979090E (pt) | Compostos de aminoaçúcar, glicosaminoglicano ou do tipo glicosaminoglicano, e s-adenosilmetionina | |
| BR0009063A (pt) | Composições de resina de epóxido estáveis aarmazenamento | |
| WO2000045853A3 (en) | Treatment of tumors with genetically engineered herpes virus | |
| DE69519385D1 (de) | Chinazolinon-arzneimittel sowie deren verwendung | |
| NO953995L (no) | Ionenolymere som anthelmintica i dyr | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| NO983530D0 (no) | Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler | |
| EA200100963A1 (ru) | Средство для лечения артрита | |
| ATE307497T1 (de) | Pharmazeutische zusammensetzung | |
| DK1152776T3 (da) | Bionedbrydelig, injicerbar oligomer-polymer-sammensætning | |
| UY25338A1 (es) | Método para tratar copd | |
| WO2000047197A3 (en) | Alkylating agents for treatment of cellular proliferation | |
| ATE425731T1 (de) | Pharmazeutische zusammensetzungen eines nichtmagensaftresistenten protonenpumpen-hemmers mit einer carbonat- und bicarbonatsalzkombination | |
| EP0974358A3 (en) | Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases |